Topical Oxygen Therapy Versus Kenacort in Recurrent Aphthous Stomatitis - A Comparative Study
Indian Journal of Dental Research · 2026-04 · 37 (2) · 163-167
DOI: 10.4103/ijdr.ijdr_193_26 ↗Abstract
Abstract Background: Recurrent aphthous stomatitis (RAS) is a common painful oral mucosal disorder causing significant discomfort and functional limitation. Conventional treatments mainly provide symptomatic relief with limited effect on healing. Topical oxygen therapy is a novel, non-invasive modality that may enhance tissue oxygenation and promote mucosal repair. Aim: To evaluate the effectiveness of topical oxygen therapy in reducing ulcer size and pain in patients with RAS and compare its outcomes with Kenacort gel. Materials and Methods: Patients with RAS received either topical oxygen therapy or Kenacort gel. Clinical assessments were performed at baseline and follow-up visits. Reduction in ulcer size was the primary outcome, while pain reduction and healing time were secondary outcomes. Statistical significance was set at P < 0.05. Results: Both groups showed significant reductions in ulcer size and pain over time ( P < 0.001). On Day 7, greater ulcer size reduction ( P = 0.07) and lower pain scores ( P = 0.09) were observed in the oxygen therapy group, although differences were not statistically significant. By Day 14, no significant inter-group differences were found in ulcer size ( P = 0.18) or pain scores ( P = 0.15). Complete healing occurred in 70% of the Kenacort group and 77% of the oxygen therapy group ( P = 0.56). Conclusion: Topical oxygen therapy showed clinical outcomes comparable to Kenacort and may be considered a safe alternative or adjunctive treatment for RAS.
EUVIMED